Brief: 3SBio Terminates Exclusive License Agreement With Astrazeneca
28/02/2023 13:47
Feb 28 (Reuters) - 3SBio Inc 1530.HK :
* TERMINATION OF EXCLUSIVE LICENSE AGREEMENT WITH
ASTRAZENECA IN
RESPECT OF BYETTA AND BYDUREON
Source text for Eikon: ID:
Further company coverage: 1530.HK